Table 3 IL28B genotype expression in non-diabetic and diabetic groups according to grades of fibrosis
| Variable | CC | CT | TT | χ2 | P | |
|---|---|---|---|---|---|---|
|
G1 a and b non-diabetic (n = 80) |
Fibrosis (n = 40) | 18 (45.0%) |
15 (37.5%) |
7 (17.5%) | 2.65 | 0.27* |
|
Cirrhosis (n = 40) | 11 (27.5%) |
20 (50%) |
9 (22.5%) | |||
| OR(95%CI) | 1 |
2.18 (0.71–6.78) |
2.1 (0.52–8.79) | |||
|
GII a and b diabetic (n = 80) |
Fibrosis (n = 40) | 6 (15.0%) |
26 (65.0%) |
8 (20.0%) | 2.26 | 0.32* |
|
Cirrhosis (n = 40) | 5 (12.5%) |
21 (52.5%) |
14 (35.0%) | |||
| OR(95%CI) | 1 |
0.97 (0.22–4.36) |
2.1 (0.39–11.87) | |||